Trastuzumab beyond progression for HER2 positive metastatic breast cancer: Progression-free survival on first-line therapy predicts overall survival impact

Daniel Rayson; Sarah Lutes; Gordon Walsh; Marlene Sellon; Bruce Colwell; Mark Dorreen; Arik Drucker; Alwin Jeyakumar; Tallal Younis

doi:10.1111/tbj.12284

Trastuzumab beyond progression for HER2 positive metastatic breast cancer: Progression-free survival on first-line therapy predicts overall survival impact

Daniel Rayson, Sarah Lutes, Gordon Walsh, Marlene Sellon, Bruce Colwell, Mark Dorreen, Arik Drucker, Alwin Jeyakumar, Tallal Younis

Research output: Contribution to journal › Article › peer-review

13 Citations (Scopus)

Original language	English
Pages (from-to)	408-413
Number of pages	6
Journal	Breast Journal
Volume	20
Issue number	4
DOIs	https://doi.org/10.1111/tbj.12284
Publication status	Published - 2014
Externally published	Yes

ASJC Scopus Subject Areas

Internal Medicine
Surgery
Oncology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/tbj.12284

Cite this

@article{1232119aff1b45638371a579b9edf1b6,

title = "Trastuzumab beyond progression for HER2 positive metastatic breast cancer: Progression-free survival on first-line therapy predicts overall survival impact",

author = "Daniel Rayson and Sarah Lutes and Gordon Walsh and Marlene Sellon and Bruce Colwell and Mark Dorreen and Arik Drucker and Alwin Jeyakumar and Tallal Younis",

year = "2014",

doi = "10.1111/tbj.12284",

language = "English",

volume = "20",

pages = "408--413",

journal = "Breast Journal",

issn = "1075-122X",

publisher = "Wiley-Blackwell",

number = "4",

}

TY - JOUR

T1 - Trastuzumab beyond progression for HER2 positive metastatic breast cancer

T2 - Progression-free survival on first-line therapy predicts overall survival impact

AU - Rayson, Daniel

AU - Lutes, Sarah

AU - Walsh, Gordon

AU - Sellon, Marlene

AU - Colwell, Bruce

AU - Dorreen, Mark

AU - Drucker, Arik

AU - Jeyakumar, Alwin

AU - Younis, Tallal

PY - 2014

Y1 - 2014

UR - http://www.scopus.com/inward/record.url?scp=84903736732&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84903736732&partnerID=8YFLogxK

U2 - 10.1111/tbj.12284

DO - 10.1111/tbj.12284

M3 - Article

C2 - 24985529

AN - SCOPUS:84903736732

SN - 1075-122X

VL - 20

SP - 408

EP - 413

JO - Breast Journal

JF - Breast Journal

IS - 4

ER -

Trastuzumab beyond progression for HER2 positive metastatic breast cancer: Progression-free survival on first-line therapy predicts overall survival impact

ASJC Scopus Subject Areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this